Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Louise Rodino-klapac currently holds 203,900 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Louise Rodino-klapac has been a net buyer of SRPT stock. They have purchased $299.9K and sold $0 worth of shares.
Louise Rodino-klapac's most recent insider trade was on Sep 4, 2026, when they sold 21,423 shares at $22.22 per share.
Louise Rodino-klapac serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 31 insider transactions totaling $299.9K over their tenure at the company.
Louise Rodino-klapac holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Louise Rodino-klapac has shown a buying trading pattern, with $299.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Louise Rodino-klapac was on Sep 4, 2026, when they sold $476.0K worth of SRPT shares. This transaction involved 21,423 shares at $22.22 per share.
Louise Rodino-klapac currently owns 203,900 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Louise Rodino-klapac's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Louise Rodino-klapac has 31 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Louise Rodino-klapac and 40,000+ other insiders.